Hippo Holdings came into this Q3 2026 report with its stock up solidly over the past month yet off a touch today, slipping about 1.4% to US$36.64. The reputation is high growth and premium pricing on a rich P/E multiple. The print is about something more basic. Revenue landed at US$156 million and net income reached US$8.8 million, supported by what management calls a fifth straight quarter of underwriting profitability and a tighter combined ratio profile. The gap between a modest price dip and sturdier fundamentals is what matters for you now.
Like the underwriting progress at Hippo Holdings but unsure about paying up for a rich P/E and modest headline profit today? Compare this setup with our list of solid balance sheet and fundamentals stocks (25 results) .
Q3 2026 Earnings Summary
-
Revenue, Q3 2026 vs. Q3 2025:US$156 million vs. US$120.6 million (up about 29%)
-
Net Income, Q3 2026 vs. Q3 2025:US$8.8 million vs. US$98.1 million (sharply lower due to an unusually high prior period figure)
-
Basic EPS, Q3 2026 vs. Q3 2025:US$0.33 vs. US$3.90 (down significantly compared with last year's elevated result)
-
Combined Ratio, Q3 2026 vs. Q2 2026 (profitability metric for insurers):98.4% vs. 95.8% (slightly higher and still within the underwriting profitability range management has been highlighting)
Hippo's fastest growth is now in casualty and CMP, not home insurance. Ask Charlie what's driving Hippo's big mix shift away from homeowners .
Hippo's Bull Story Hinges On Program Scale, Not Homeowners
The bullish script for Hippo Holdings rests on turning a diversified program platform and AI tooling into steadily compounding underwriting and fee earnings. The ambition is clear.
"Bullish analysts expect Hippo Holdings to keep scaling its diversified program carrier platform and AI-enabled operations, with the goal that underwriting profits and fee income will continue to build on the profitability already visible by mid 2026."
Q3 gives concrete markers. The fifth consecutive quarter of underwriting profitability, a 98.4% combined ratio, and a roughly 10 point drop in the expense ratio all line up with that goal. Program and fee income of US$19.7 million, growing faster than total revenue, supports the thesis that a broader program mix and AI driven efficiencies are starting to matter in the numbers.
One Narrative disagrees with today's price. → See where this Narrative says Hippo Holdings should trade .
Hippo Margins Face Early Soft‑Market Friction
Bearish investors worry that Hippo Holdings will struggle to protect underwriting quality once property markets soften and claims pressure returns.
"Despite substantial use of rate filings and reinsurance structures to manage volatility, a softer property market with slower rate momentum may constrain future pricing actions. If catastrophic losses or claims inflation re emerge at prior levels, the current combined ratio could come under renewed pressure and reduce profitability."
This quarter, the 98.4% combined ratio stayed just inside underwriting profit, but it did so with a higher 6.5% cat load and accident year ex cat loss ratio at 49.9%. The expense ratio improvement did the heavy lifting. That mix supports the concern that a softer market leaves limited room for future shocks.
Hunt For Quiet Mispricings Now
Hippo Holdings recently highlighted how a modest share price change can coincide with significant shifts in the business. The real opportunity is identifying stocks that could be undervalued before the market updates their valuations.
-
Company 1 - 48% below our estimate - co-designs hardware with customers so engineering and supply chain choices embed into extended AI and industrial programs.
-
Company 2 - 38% below our estimate - expands coconut based beverages into additional retailers and uses private label partnerships to increase plant utilization and spread fixed costs.
-
Company 3 - 34% below our estimate - supplies glass, ceramics and optical components under long duration contracts tied to telecom networks, data centers, solar projects and laboratory demand.
Those are three of them. See every one of the 29 undervalued companies on it →
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include HIPO .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
